Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spine scan showdown: MRI vs PET/CT – safety and clarity compared

NCT ID NCT07640386

Knowledge-focused Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 120 adults with neck or lower back spine issues to compare two types of scans: contrast-enhanced MRI and FDG-PET/CT. Researchers checked how clear the images were and whether the scans caused any short-term changes in kidney function or blood counts. The goal was to help doctors choose the best imaging method for spinal problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

120 people

The number who actually took part.

Started

Apr 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited from the general population through community outreach, advertisements, and screening visits. Individuals who meet the eligibility criteria will be invited to participate.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Clinically suspected or confirmed cervical or lumbar spinal pathology. * Presence of symptoms suggestive of spinal disease, including radiculopathy, localized spinal pain, neurological deficits, or suspected metastatic involvement. * Referred for diagnostic evaluation with contrast-enhanced MRI or FDG-PET/CT according to routine clinical indications. * Availability of baseline clinical and laboratory data, including renal function assessment. * Ability to provide informed consent. Exclusion Criteria: * Severe renal impairment (eGFR \<30 mL/min/1.73 m²) or acute kidney injury. * Known hypersensitivity to gadolinium-based contrast agents or 18F-FDG. * Contraindications to MRI, including non-compatible metallic implants or severe claustrophobia. * Pregnancy or breastfeeding. * Uncontrolled diabetes mellitus (blood glucose \>200 mg/dL at the time of PET/CT examination). * Active systemic infection or inflammatory condition requiring immediate treatment. * Inability to complete the required imaging procedures. * Incomplete clinical, laboratory, or imaging data required for study evaluation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contrast-enhanced mri and FDG-pet/CT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

vertebral column disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contrast-enhanced mri and FDG-pet/CT Short-term renal-hematologic safety Spinal pathology

Contacts and locations

Locations

  • (MISR University Scientific Research Innovation Committee,

    Giza, Giza Governorate, 43556, Egypt